Abstract Chemobiosynthesis has been used to prepare analogs of erythromycins having unique functional groups at the 15-position. Using diketide thioester feeding to genetically engineered Streptomyces coelicolor, analogs of 6-deoxyerythronolide B were prepared having 15-fluoro, 15-chloro, and 15-azido groups. Bioconversion using a genetically engineered mutant of Saccharopolyspora erythraea was used to produce 15-fluoroerythromycin A and 15-azidoerythromycin A. These new erythromycin analogs provide antibacterial macrolides with unique physicochemical properties and functional groups that allow for selective derivatization.
Introduction
The search for new macrolide antibacterial agents has been driven by the need to improve the spectrum, stability, and physicochemical properties of existing antibiotics. Erythromycin A (1) has been successfully used to treat respiratory infections for over 50 years, but suffers from marked instability, poor bioavailability, undesired gastrointestinal side effects, and an increasingly limited spectrum of activity with the rise in macrolidelincosamide-streptogramin B MLS(B)-resistant bacteria. Chemical derivatization of erythromycin A has now been thoroughly investigated as a means of overcoming most of these limitations. For example, 6-O-methylation to produce clarithromycin and ring expansion of the 9-oxime to produce azithromycin have been highly successful at stabilizing the macrolide, but with no marked improvements in spectrum. Chemical conversion of 1 to the ketolides telithromycin and cethromycin has improved both the stability and spectrum of activity, although at the expense of rather complex chemistry. Replacement of the cladinose sugar with various acyl groups has yielded acylides with improved spectrum, in part due to overcoming inducible MLS(B) resistance [1] . Given the extensive medicinal chemistry that has been performed, there appear to be few remaining positions on the erythromycin scaffold that have not been modified. Further development of erythromycin thus requires radically new technology.
The production of novel erythromycins through chemobiosynthesis has been previously reported [2, 3] . In this process, synthetic starter units are introduced into the erythromycin polyketide by feeding a diketide analog to an engineered strain in which the ketosynthase domain of the initial polyketide synthase module has been inactivated. This technology has been used to make chemically rather conservative changes to the erythromycin structure, for example replacing the starting propionyl group with a butyryl group. Another technology using a polyketide synthase (PKS) having a genetically engineered load domain from the avermectin PKS has also provided erythromycins with chemically conservative changes to the starter unit, such as replacing the starting propionyl group with a cyclopentyl group [4] . These erythromycins
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Preparation of Erythromycin Analogs Having Functional Groups at C-15
Partition Coefficients
Log D values were estimated by two methods. In the first, the individual compounds 1 and 2 were partitioned between 1-octanol and 0.1 M sodium N-tris(hydroxymethyl)methyl-2-aminoethanesulfonate (TES-Na ϩ ), pH 7.4, and the amount of compound remaining in the aqueous phase was determined by HPLC analysis. In a second method, a mixture of equal amounts of 1 and 2 in 10 mM sodium N-2-(hydroxyethyl)-piperazine-NЈ-2-ethanesulfonate (HEPES-Na ϩ ), pH 7.4, was stirred vigorously with an equal volume of buffersaturated 1-octanol for 24 hours, and the aqueous phase was analyzed by HPLC, revealing an 80 : 20 ratio of 2 to 1.
3-Fluoropropanal (4)
Trichloroisocyanuric acid (17.0 g, 73 mmol) was added in ca. 1 g portions over 1 hour to a vigorously stirred mixture of 3-fluoropropanol (15.6 g, 200 mmol), NaHCO 3 (16.8 g, 200 mmol), and TEMPO (0.35 g, 2.2 mmol) in CH 2 Cl 2 (300 ml) and water (10 ml). The temperature was kept at 20ϳ25°C using a water bath. After addition was complete, the mixture was stirred until the orange color faded to a pale yellow (approximately 30 minutes). The resulting solution was decanted from the gummy white residue, filtered through a pad of silica gel (5 g), and dried over MgSO 4 (10 g The concentration of 4 was determined by dilution of 50 m l of the solution into 300 m l of CDCl 3 and recording the 1 H-NMR spectrum. The integral of the CH 2 Cl 2 peak (d 5.28) was taken as representing 31.2 M protons in the neat solution, and compared to the integral of the aldehyde peak (d 9.82) such that the concentration of 4 was estimated using the formula: [4] ϭ(integral of CHO)/(integral of CH 2 Cl 2 )*31.2. This procedure provided an approximately 0.5 M solution of 4 in CH 2 Cl 2 , which was stable for several weeks when stored at Ϫ20°C.
3-Azidopropanal (5)
Prepared according to [8] . 1 (؎)-N-[u-5-X-3-Hydroxy-2-methylpentanoyl]-2-benzoxazolones (7, 8, 9) Aldehydes 4ϳ6 were converted into their racemic syn N-[u-5-X-3-hydroxy-2-methylpentanoyl]-2-benzoxazolone aldol adducts 7ϳ9, and the aldol adducts were converted into the thioesters 10ϳ12 using the procedure described by [9] . 
Preparation of 15-X-6-Deoxyerythronolide B Analogs (13ϳ15)
A seed culture of Streptomyces coelicolor CH999/pJRJ2 was made by inoculating 1 ml of frozen mycelium into a 250 ml baffled flask containing 50 ml of FKA medium (corn starch, 45 g/liter; corn steep liquor, 10 g/liter; dried, inactivated brewers yeast, 10 g/liter; and CaCO 3 , 1 g/liter), 0.050 ml of 50 mg/ml thiostrepton in DMSO (filter sterilized), and 0.500 ml of 50% Antifoam B (JT Baker). The flask was incubated at 30°C with shaking at 175 rpm for 48 hours (Innova floor shaker). The culture was transferred into a 2.8-liter baffled flask containing 500 ml of FKA medium, 0.500 ml of 50 mg/ml thiostrepton in DMSO, and 5 ml of 50% Antifoam B, and the flask was incubated at 30°C with shaking at 175 rpm for 48 hours.
A 10-liter stirred tank bioreactor (B. Braun) was autoclaved, filled with 5 liters of sterile FKA medium and 5 ml of 50 mg/ml thiostrepton in DMSO, and then inoculated with 500 ml (10%) of seed culture. The bioreactor was run for 24 hours at 30°C with stirring at 600 rpm, sparged with air at 1.33 LPM, and the pH was maintained at 6.50 by automated addition of 2.5 N NaOH and 2.5 N H 2 SO 4 .
Three liters of the above culture were used to inoculate a 100-liter bioreactor containing 55 liters of sterile FKA medium with 2 g/liter Tastone 310 added prior to sterilization. The initial fermentor agitation rate was set at a tip speed of 2.5 m/second, the temperature was maintained at 30°C, the pH was controlled at pH 6.5 by automated addition of 2.5 N NaOH and 2.5 N H 2 SO 4 , and the airflow was set at 0.4 vvm. Foaming was controlled by automated addition of 50% Antifoam B. During the fermentation, the dissolved oxygen was maintained at Ͼ50% air saturation by cascade control using the agitation rate (tip speed of 2.5ϳ3.0 m/second) and back pressure (0.1ϳ0.4 bar) in that order. After 24 hours post-inoculation, a 400 g/liter solution of the appropriate thioester 10ϳ12 in DMSO was added to a final concentration of 1 g/liter. Titers of 13ϳ15 were monitored by HPLC, and the culture was harvested by centrifugation when a maximum titer was reached.
The 13ϳ15 was isolated by solid phase extraction. The broth was clarified by centrifugation and loaded onto a column containing HP-20 resin (Rohm and Haas) at a concentration of 1 liter resin/20 g 15-X-6-deoxyerythronolide B. The column was then equilibrated with 5 column volumes of water at a flow rate of 2ϳ4 ml/cm 2 -minute. The loaded resin was washed with 2 column volumes of water followed by 2 column volumes of 30% methanol in water. The compound was eluted from the resin with methanol. The fractions containing desired compound were identified by HPLC with ELSD detection, then were pooled and the volatiles were removed under reduced pressure. The dried solids were extracted with 3ϳ5 liters of methanol and filtered to yield a solution containing 6ϳ10 mg/ml of the compound, which was diluted with an equal volume of water. This solution was loaded onto a column of HP20SS (1 liter resin/20 g of compound), which was then washed with 2 column volumes of 50% aqueous methanol. The compound was then eluted with 70% methanol in water, and the fractions were analyzed by HPLC. Product-containing fractions were pooled and evaporated to dryness.
15-Fluoro-6-deoxyerythronolide B (13)
Crystals from ether/hexane, mp 122ϳ123°C. 
15-Chloro-6-deoxyerythronolide B (15)
Preparation of Erythromycin A analogs (2, 3)
A seed culture of Saccharopolyspora erythraea K39-14V
was made by inoculating a 1 ml aliquot of frozen mycelium into each of three 250 ml baffled flasks containing 50 ml of V1 medium (corn starch, 16 g/liter; corn dextrin, 10 g/liter; soya meal flour, 15 g/liter; corn steep liquor, 5 g/liter; soy bean oil, 6 g/liter; sodium chloride, 2.5 g/liter; ammonium sulfate, 1 g/liter; and CaCO 3 , 4 g/liter) and 0.100 ml of Antifoam B. The flasks were incubated at 34°C with shaking at 175 rpm for 48 hours (Innova floor shaker). Each culture was transferred into a 2.8-liter baffled flask containing 500 ml of V1 medium and 1 ml of Antifoam B, and the flasks were incubated at 34°C with shaking at 175 rpm for 48 hours. Three 10-liter stirred tank bioreactors (B. Braun) were autoclaved, and each filled with 10 liters of sterile 50% F1 medium (corn starch, 17.5 g/liter; corn dextrin (type 3), 16 g/liter; soy meal flour, 16.5 g/liter; calcium carbonate, 4 g/liter, corn steep liquor, 6 g/liter; soy bean oil, 3 g/liter; sodium chloride 2.5 g/liter; and ammonium sulfate, 1 g/liter). The fermentor agitation rate was set at a tip speed of 2ϳ4 m/second, the pH was controlled at pH 7.0 by automated addition of 2.5 N NaOH and 2.5 N H 2 SO 4 , the temperature was maintained at 34°C, and the airflow was set at 0.15 vvm. Foaming was controlled by automated addition of 50% Antifoam B. Each fermentor was inoculated with a 500-ml seed culture prepared above. During the fermentation, the dissolved oxygen was maintained at Ͼ80% air saturation by cascade control using agitation rate (tip speed of 2ϳ4 m/second), airflow (0.15ϳ0.5 vvm), and oxygen enrichment in that order. After 24 hours post-inoculation, a continuous 2 g/liter/day dextrin feed (150 g/liter dextrin in deionized water) was initiated, and a 4% w/v solution of 13 or 14 was added to a final concentration of 250ϳ300 mg/liter. Samples were analyzed by HPLC every 12 hours. After cessation of erythromycin analog production (ca. 60 hours), the culture was harvested by centrifugation.
The erythromycin analog was isolated by solid phase extraction. The broth was adjusted to pH 9 using 2.5 N NaOH, clarified by centrifugation, and loaded onto a column containing HP-20 resin (Rohm and Haas) at a concentration of 1 liter resin/20 g of erythromycin A analog. The column was then equilibrated with 5 column volumes of water at a flow rate of 2ϳ4 ml/cm 2 -minute. The loaded resin was washed with 2 column volumes of water. The erythromycin analog was eluted from the resin with 5 column volumes of methanol. The fractions containing erythromycin analog were identified by HPLC, pooled, and the volatiles were removed under reduced pressure. The dried solids were mixed with 800 ml of acetone and 3.2-liter of hexane for 20 minutes. The mixture was then filtered using a #4 Whatman filter paper. The solids were extracted twice in this manner, and the filtrates were combined and evaporated.
The crude product was dissolved in methanol and diluted with an equal volume of water. This solution was loaded onto a column of HP20SS (1 liter resin/20 g of erythromycin analog), which was then washed successively with 1 column volume of 50% aqueous methanol, 3 column volumes of 3 : 2 methanol/water, 3 column volumes of 7 : 3 methanol/water, 10 column volumes of 4 : 1 methanol/water, and finally 5 column volumes of 100% methanol. The fractions were analyzed by HPLC. Productcontaining fractions were pooled and evaporated to dryness. 
15-Fluoroerythromycin
Results and Discussion
Diketide thioesters 10ϳ12 were prepared using a titaniummediated aldol condensation between N-propionyl-2-benzoxazolone and a 3-substituted propanal to give racemic syn-aldol adducts 7ϳ9. The 2-benzoxazolone auxiliary was readily displaced by the thiolate anion of either Nacetylcysteamine or N-propionylcysteamine to provide the racemic syn diketide thioester (Scheme 1, RϭMe or Et) [9] . The N-propionylcysteamine thioester was chosen for 10 as this gave a more conveniently handled, solid material. The required 3-azidopropanal (5) and 3-chloropropanal (6) were prepared by addition of the corresponding acids to acrolein, with the addition of HCl being titrated using dicinnamylacetone as indicator [10] . As an efficient synthesis and isolation of 3-fluoropropanal (4) had not been previously reported, a simple process suitable for the production of this unstable synthon in a form useable in the titanium-mediated aldol without purification was developed. Numerous conditions for oxidation of 3-fluoropropanol were examined, yet most resulted in significant decomposition of the sensitive product or the generation of byproducts that were incompatible with the subsequent aldol reaction. TEMPO-catalyzed oxidation using NaOCl resulted in significant quantities of acrolein due to base-catalyzed elimination of HF, even under buffering with NaHCO 3 , and the large proportion of water involved led to low recoveries of the relatively watersoluble 4. We found that the basicity of the reaction was ameliorated, and the proportion of water used lessened, by using trichloroisocyanuric acid as oxidant along with a slurry of NaHCO 3 in a minimal volume of water in CH 2 Cl 2 . Thus, treatment of an equimolar mixture of 3-fluoropropanol and NaHCO 3 in CH 2 Cl 2 containing Ͻ10% v/v water with catalytic TEMPO and one-third molar equivalent of trichloroisocyanuric acid, followed by decanting and drying of the resulting solution, provided a moderately stable solution of 4 in ϳ80% yield.
The titanium-mediated aldol condensation between N-propionyl-2-benzoxazolone and the base-sensitive aldehydes 4 or 6 gave improved results using N-methylmorpholine rather than triethylamine as base. Use of the weaker base minimized formation of the acrolein adduct. Azidopropanal 5 was efficiently condensed using triethylamine as base.
The racemic diketide thioesters 10ϳ12 were converted into the corresponding 6-deoxyerythronolide B analogs 13ϳ15 using Streptomyces coelicolor CH999/pJRJ2 as previously described for other analogs [11] . While 14 was successfully prepared by feeding of 11, concerns over the large-scale synthesis of 5 led us to adopt an indirect route to this analog. Feeding of the chloride 12 produced 15 in good yield, demonstrating that the chemobiosynthesis process can tolerate a reactive primary alkyl halide. Conversion of 15 into azide 14 was readily accomplished by reaction with NaN 3 in DMF.
Subsequent bioconversion of 13 and 14 using Saccharopolyspora erythraea K39-14V, an engineered mutant strain having an inactivated polyketide synthase, provided the erythromycin A analogs 2 and 3 [12] . The presence of the functional groups at the 15-position did not adversely affect the ability of the tailoring enzymes to act on these substrates, such that 13 and 14 were predominantly bioconverted into their erythromycin A analogs. Bioconversion of 15 provided only low titers of the corresponding 15-chloroerythromycin A.
The erythromycin A analogs described here show in vitro antibacterial activity comparable to that of erythromycin A as shown in Table 1 . (As compounds 2 and 3 were tested on separate days, Table 1 gives a comparison of the MIC values with those for 1 measured on the same day as either 2 or 3.) The introduction of chemical handles at the 15-position is itself not deleterious to antibacterial activity. Against macrolide-susceptible pneumococci, the MIC values of 2 and 3 were similar to those of 1. Activities against mef(A)-containing pneumococci were comparable for 1 and 3, while MIC values for 2 were generally two-fold higher. With the exception of one pneumococcal strain, all compounds were relatively inactive against erm(B)-containing S. pneumoniae or S. haemolyticus isolates, with MIC values Ͼ16 mg/ml. In contrast, 3 was selectively more active than the other two antibiotics against the Gramnegative respiratory pathogen H. influenzae, with MIC values two-to four-fold lower than 1 or 2.
Fluorine substitution is commonly used in medicinal chemistry to alter the lipophilicity or metabolic stability of a drug, and its inclusion often has beneficial effects on activity, protein binding, and cell penetration [13] . Flurithromycin, (8S)-8-fluoroerythromycin A, had higher serum and tissue levels than erythromycin at similar doses, demonstrative of the beneficial pharmacological effect of fluorination on the macrolide molecule [14] . Measurement of partitioning between 1-octanol and water at pH 7.4 indicates that 2 (log DХ0.3) is significantly less lipophilic than 1 (log DХ0.9). Thus, 2 is a scaffold for antibacterial development having unique pharmacological properties while retaining the fundamental bioactivity of 1.
Another erythromycin analog, 3, has a unique chemical handle that allows selective derivatization to create new analogs. Reduction of the azido group and subsequent functionalization of 3 has been recently described [15] .
In summary, we have shown that chemobiosynthesis can provide novel analogs of erythromycin that are inaccessible by traditional chemical methods. These analogs contain unique functional groups that alter the physicochemical properties and allow for selective derivatization of the macrolide core, and so enable a new area of investigation into the generation of improved macrolide antibacterial agents.
